Ampicillin plus Ceftriaxone for High-Level Aminoglycoside-Resistant Enterococcus faecalis Endocarditis

  1. Joan Gavaldá, MD, PhD;
  2. Oscar Len, MD;
  3. Benito Almirante, MD; and
  4. Albert Pahissa, MD
  1. From Hospital Vall d'Hebron, 08035 Barcelona, Spain.

    IN RESPONSE:

    We read with interest the letter by Dr. Singh regarding our article. First, we would like to clarify that the cure rate for HLAR E. faecalis endocarditis was 71.4%, far greater than the best cure rate reached with a cell-wall–susceptible agent alone or in combination with other therapy. After careful review of our article, we …

    Summary for Patients

    « Previous | Next Article »Table of Contents